arrow
R

Raj Persad

bristol urological institute
H指数:55
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy

根治性前列腺切除术后总生存的中间临床终点替代指标

2026-06-150
OAAI
REFINING PATIENT SELECTION FOR SALVAGE RADICAL PROSTATECTOMY BEYOND EAU RECOMMENDATIONS: DEVELOPMENT OF A NOMOGRAM TO ESTIMATE METASTASIS-FREE SURVIVAL

优化超越欧洲泌尿外科学会推荐标准的拯救性根治性前列腺切除术患者选择:开发用于预测无转移生存率的列线图

2026-05-010
PRE
AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study

AI决策支持以提高前列腺活检效率:一项回顾性多中心、多扫描仪研究

2026-02-200
OAAI
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study

人工智能驱动的前列腺癌检测:一项多中心、多扫描仪验证研究

2025-02-285
OA
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)

根治性前列腺切除术后无,短期或长期雄激素剥夺疗法与术后放疗的随机试验: radical-hd的三向比较结果 (NCT00541047)

2024-11-011
OA
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)

根治性前列腺切除术 (RP) 后放疗 (RT) 的时机: radical-rt试验 (NCT00541047) 的长期结果

2024-07-019
OAAI
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience

在> 70岁的患者中,局部消融治疗局部临床显着前列腺癌后的结果评估: 多研究所,多能量15年的经验

2023-07-017
PRE
Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort
2023-07-019
PRE
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial
RADIOLOGY
IF15.2
2023-04-015
OAAI
RADICALS-HD: Reflections before the Results are Known
2022-09-016
OAAI
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guerin-exposed High-risk Non-muscle-invasive Bladder Cancer

国际膀胱癌组织关于卡介苗暴露高危非肌层浸润性膀胱癌患者临床试验设计的共识声明

2022-07-0143
PRE
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy
2022-04-2321
OAAI
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience

在1379名非转移性前列腺癌患者中使用高强度聚焦超声进行聚焦治疗后的癌症控制结果: 多机构15年的经验

2022-04-0165
OA
The Is mpMRI Enough or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy
2021-09-0120
OAAI
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control
2021-05-0115
OAAI
Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis
2021-04-1247
PREAI
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial

机器人辅助根治性前列腺切除术中的NeuroSAFE冷冻切片: NeuroSAFE证明可行性随机对照试验的围手术期和组织病理学结果

2021-03-2931
OAAI
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study
2021-01-2838
PREAI